Levket-AM Tablet

Description

Levocetirizine 5 mg + Ambroxol 75 mg + Montelukast 10 mg Tablet is an advanced respiratory formulation designed to provide effective relief from allergic conditions, cough, bronchial congestion, and asthma-related symptoms. This combination works by controlling allergic reactions, reducing airway inflammation, and promoting mucus clearance for better breathing comfort.

Manufactured in WHO-GMP certified facilities, this tablet ensures high quality, safety, and reliable therapeutic outcomes. Due to its broad clinical usage, it is a high-demand product and an excellent addition to any pharma franchise respiratory range.

Key Benefits:

✔ Helps relieve allergic symptoms like sneezing and runny nose
✔ Supports bronchial airway relaxation
✔ Promotes mucus clearance and cough relief
✔ Helps manage asthma and respiratory allergies
✔ Improves breathing comfort
✔ WHO-GMP certified quality manufacturing
✔ High demand respiratory product for pharma franchise

Composition:

Levocetirizine 5 mg – Anti-allergic agent
Ambroxol 75 mg (SR) – Mucolytic and expectorant
Montelukast 10 mg – Leukotriene receptor antagonist for asthma and allergy control

Indications / Uses:

Allergic rhinitis
Chronic cough with mucus
Bronchial asthma
Respiratory tract allergies
Sinus congestion and airway inflammation

Dosage Form:

Sustained Release Tablets
(Dosage should be taken as directed by the physician)

Packaging:

Alu-Alu packaging
Customizable franchise packaging available

Pharma Franchise Opportunity:

We offer Levocetirizine + Ambroxol + Montelukast Tablet Pharma Franchise with:

✅ Monopoly franchise rights
✅ WHO-GMP certified manufacturing
✅ Strong demand respiratory and allergy product
✅ Promotional and marketing support
✅ Competitive pricing with attractive business margins

This product is a valuable addition to respiratory and allergy pharma franchise portfolios, ensuring strong prescription demand and repeat market sales.